Literature DB >> 26139989

Inhibition of ileal bile acid transporter: An emerging therapeutic strategy for chronic idiopathic constipation.

Paula Mosińska1, Jakub Fichna1, Martin Storr1.   

Abstract

Chronic idiopathic constipation is a common disorder of the gastrointestinal tract that encompasses a wide profile of symptoms. Current treatment options for chronic idiopathic constipation are of limited value; therefore, a novel strategy is necessary with an increased effectiveness and safety. Recently, the inhibition of the ileal bile acid transporter has become a promising target for constipation-associated diseases. Enhanced delivery of bile acids into the colon achieves an accelerated colonic transit, increased stool frequency, and relief of constipation-related symptoms. This article provides insight into the mechanism of action of ileal bile acid transporter inhibitors and discusses their potential clinical use for pharmacotherapy of constipation in chronic idiopathic constipation.

Entities:  

Keywords:  Bile acids; Chronic idiopathic constipation; Ileal bile acid transporter

Mesh:

Substances:

Year:  2015        PMID: 26139989      PMCID: PMC4481438          DOI: 10.3748/wjg.v21.i24.7436

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  49 in total

1.  Colonic mucosal proliferation is related to serum deoxycholic acid levels.

Authors:  T Ochsenkühn; E Bayerdörffer; A Meining; M Schinkel; C Thiede; V Nüssler; M Sackmann; R Hatz; A Neubauer; G Paumgartner
Journal:  Cancer       Date:  1999-04-15       Impact factor: 6.860

2.  Clinical trial: the efficacy and tolerability of velusetrag, a selective 5-HT4 agonist with high intrinsic activity, in chronic idiopathic constipation - a 4-week, randomized, double-blind, placebo-controlled, dose-response study.

Authors:  M Goldberg; Y-P Li; J F Johanson; A W Mangel; M Kitt; D T Beattie; K Kersey; O Daniels
Journal:  Aliment Pharmacol Ther       Date:  2010-09-22       Impact factor: 8.171

Review 3.  Bile acids: short and long term effects in the intestine.

Authors:  Antal Bajor; Per-Göran Gillberg; Hasse Abrahamsson
Journal:  Scand J Gastroenterol       Date:  2010-06       Impact factor: 2.423

4.  Linaclotide: new mechanisms and new promise for treatment in constipation and irritable bowel syndrome.

Authors:  Ruchit Sood; Alexander C Ford
Journal:  Ther Adv Chronic Dis       Date:  2013-11       Impact factor: 5.091

5.  Deoxycholic acid suppresses p53 by stimulating proteasome-mediated p53 protein degradation.

Authors:  D Qiao; S V Gaitonde; W Qi; J D Martinez
Journal:  Carcinogenesis       Date:  2001-06       Impact factor: 4.944

6.  Randomised clinical trial: The ileal bile acid transporter inhibitor A3309 vs. placebo in patients with chronic idiopathic constipation--a double-blind study.

Authors:  M Simrén; A Bajor; P-G Gillberg; M Rudling; H Abrahamsson
Journal:  Aliment Pharmacol Ther       Date:  2011-05-05       Impact factor: 8.171

7.  Effect of 5 days linaclotide on transit and bowel function in females with constipation-predominant irritable bowel syndrome.

Authors:  Viola Andresen; Michael Camilleri; Irene A Busciglio; April Grudell; Duane Burton; Sanna McKinzie; Amy Foxx-Orenstein; Caroline B Kurtz; Vineeta Sharma; Jeffrey M Johnston; Mark G Currie; Alan R Zinsmeister
Journal:  Gastroenterology       Date:  2007-07-03       Impact factor: 22.682

8.  Asymptomatic colorectal neoplasia and fecal characteristics: a case-control study of subjects participating in the nottingham fecal occult blood screening trial.

Authors:  Julian Little; Robert W Owen; Fresie Fernandez; Patricia G Hawtin; Michael J Hill; Richard F A Logan; Michael H Thompson; Jack D Hardcastle
Journal:  Dis Colon Rectum       Date:  2002-09       Impact factor: 4.585

9.  A randomized placebo-controlled phase IIb trial of a3309, a bile acid transporter inhibitor, for chronic idiopathic constipation.

Authors:  William D Chey; Michael Camilleri; Lin Chang; Leif Rikner; Hans Graffner
Journal:  Am J Gastroenterol       Date:  2011-05-24       Impact factor: 10.864

10.  Association between fecal bile acids and colorectal cancer: a meta-analysis of observational studies.

Authors:  Jin Lu Tong; Zhi Hua Ran; Jun Shen; Guo Quan Fan; Shu Dong Xiao
Journal:  Yonsei Med J       Date:  2008-10-31       Impact factor: 2.759

View more
  3 in total

1.  Ileal Bile Acid Transporter Inhibition Reduces Post-Transplant Diarrhea and Growth Failure in FIC1 Disease-A Case Report.

Authors:  Johanna Ohlendorf; Imeke Goldschmidt; Norman Junge; Tobias Laue; Hamoud Nasser; Elmar Jäckel; Frauke Mutschler; Eva-Doreen Pfister; Diran Herebian; Verena Keitel; Ulrich Baumann
Journal:  Children (Basel)       Date:  2022-05-05

Review 2.  Polyunsaturated Fatty Acids and Their Derivatives: Therapeutic Value for Inflammatory, Functional Gastrointestinal Disorders, and Colorectal Cancer.

Authors:  Arkadiusz Michalak; Paula Mosińska; Jakub Fichna
Journal:  Front Pharmacol       Date:  2016-12-01       Impact factor: 5.810

3.  Genome-wide association meta-analysis yields 20 loci associated with gallstone disease.

Authors:  Egil Ferkingstad; Asmundur Oddsson; Solveig Gretarsdottir; Stefania Benonisdottir; Gudmar Thorleifsson; Aimee M Deaton; Stefan Jonsson; Olafur A Stefansson; Gudmundur L Norddahl; Florian Zink; Gudny A Arnadottir; Bjarni Gunnarsson; Gisli H Halldorsson; Anna Helgadottir; Brynjar O Jensson; Ragnar P Kristjansson; Gardar Sveinbjornsson; David A Sverrisson; Gisli Masson; Isleifur Olafsson; Gudmundur I Eyjolfsson; Olof Sigurdardottir; Hilma Holm; Ingileif Jonsdottir; Sigurdur Olafsson; Thora Steingrimsdottir; Thorunn Rafnar; Einar S Bjornsson; Unnur Thorsteinsdottir; Daniel F Gudbjartsson; Patrick Sulem; Kari Stefansson
Journal:  Nat Commun       Date:  2018-11-30       Impact factor: 14.919

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.